In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

HFA Cardio Talk



Available on your favourite apps


September 2022

Lived Experiences of Dyads with a Left Ventricular Assist Device: Lessons Learned for Around the World
A. Massouh.jpg

Dr. Angela Massouh  
Beirut, Lebanon

 

Loreena-Hill.jpg

Dr. Loreena Hill
Belfast, Ireland

 

In September’s HFA Cardio Talk, Dr. Angela Massouh interviews Dr. Loreena Hill on living with a left ventricular assist device, and lessons learned from around the globe. This podcast addresses the experiences of patients living with a left ventricular assist device and their informal caregivers. It will also highlight clinical aspects of self-care and how international multidisciplinary healthcare providers can do better to assist this vulnerable group.

July 2022

Gene Editing: Paving the way to end the burden of inherited cardiomyopathies or just a useful research tool?
Emma Robinson.jpg

Dr. Emma Louise Robinson
Aurora, Colorado, U.S

 

mestroni-luisa.jpg

Prof. Luisa Mestroni 
Aurora, Colorado, U.S

 

In July’s HFA Cardio Talk podcast, Dr Emma Robinson interviews Prof Luisa Mestroni, Director of the International Familial Cardiomyopathy Registry and Co-Director of the Molecular Genetics Program of the Cardiovascular Institute in Denver. This podcast discusses current approaches to diagnosis, treatment options and support for patients and families of inherited cardiomyopathy as well as how advances in gene editing have transformed translational research, understanding of disease mechanisms and prospects for clinical care.

June 2022

HFpEF – The enigma of Heart Failure
wallner_markus.jpg

Assist. Prof. Markus Wallner
Graz, Austria

 

RudolfdeBoer2018.jpg

Prof. Rudolf de Boer
Groningen, the Netherlands

 

This podcast will discuss the most recent developments in heart failure with preserved ejection fraction (HFpEF). Prof. de Boer, HFA board member and HFpEF expert, is interviewed by Dr. Wallner, chair of the HoT Committee, and will walk us through the diagnostic and therapeutic challenges of HFpEF and provide tips and tricks for the management of patients with HFpEF.

May 2022

Insights and prospects from the Heart Failure Congress 2022, Madrid, Spain
A. Cannata.jpg

Dr. Antonio Cannata
London, UK

 

Sokolski.jpg

Dr. Mateusz Sokolski,
Wrocław, Poland

 

Tica_Otilia_2019.jpg

Dr. Otilia Țica
Oradea, Romania

 

gustafsson_finn-2015.jpg

Prof. Finn Gustafsson
Copenhagen, Denmark

 

John Cleland_photo.png

Prof. John Cleland
London, UK

 

McDonagh-Theresa-2019.jpg

Prof Theresa McDonagh
London, UK

 

Savarese_Gianluigi_2020.png

Prof. Gianluigi Savarese
Stockholm, Sweden

 

Carolyn Lam_PIC.jpeg

Prof Carolyn Lam
Singapore

 

Marco Metra.jpg

Prof. Marco Metra
Brescia, Italy

 

This podcast will discuss the insights and highlights shared by key-leaders in heart failure during the annual meeting: Heart Failure Congress, held in Madrid, Spain. Prof. Gustafson offers an overview on advanced heart failure therapies and the role of MCS (mechanical circulatory support). Prof Cleland debates when should we attempt revascularisation in heart failure patients. Prof McDonagh shares the updates and changes in the implementation of the HF guidelines in the last year, since their release. Prof Savarese highlights the best scientific statement of this year, the universal definition of Heart Failure. Prof Lam provides key message and trials in HF and also underlines the sex-differences in these patients. Prof Metra discusses the pillars and future perspectives of HF and the importance of education.

April 2022

Tips and tricks in interpretation of clinical trials
Petar Seferovic.jpg

Prof. Petar M. Seferović
Belgrade, Serbia

 

ivan-milinkovic-2019.jpg

Dr. Ivan Milinković
Belgrade, Serbia

 

The podcast discusses how major clinical trials changed the perspective on how randomized clinical trials are designed, conducted and interpreted. It gives the insight into major positive and negative aspects of the clinical trials, which results influenced the contemporary heart failure treatment

March 2022

Implementing the use of HF treatments in clinical practice
savaresse-2022.jpg

Prof. Gianluigi Savaresse
Stockholm, Sweden

 

Otilia Tica.jpg

Dr. Otilia Țica
Oradea, Romania 

 

This podcast will discuss the optimal implementation of heart failure therapies: guidelines, and challenges. It tackled how registries support implementation of care and trial design in heart failure. Prof. Gianluigi Savaresse interviewed by Dr Otilia Țica, member of HOT committee, will guide us throughout the challenges of implementing optimal therapies in HF and will offer an insight on how registries can help directly improve quality of care.

 

February 2022

The SGLT2-inhibitors revolution in Heart Failure. Current indications and future perspectives
Rosano_Giuseppe-photo-web.jpg

Giuseppe Rosano
London, UK

 

A. Cannata.jpg

Dr. Antonio Cannata
London, UK

 

This podcast will discuss the most recent and serendipitous revolution in the field of Heart Failure, the SGLT2-inhibitors, their indications and future perspectives. Prof Rosano, interviewed by Dr Cannata, will drive through the most recent evidence supporting the use of SGLT2-i in patients with heart failure. Let's see whether an apple a day truly keeps the doctor away.

 

January 2022

Medical treatment for heart failure. News and controversies from 2021 ESC heart failure Guidelines
ewa-jankowska-2019.jpg

Prof. Ewa A. Jankowska
Wroclaw, Poland

 

Sokolski.jpg

Mateusz Sokolski
Wroclaw, Poland

 

The podcast presents the news and controversies related to 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. The discussion between co-author of the guidelines and member of HOT Committee covers the important clinical aspects of medical treatment of heart failure and co-morbidities taking into account some doubts coming from guidelines and gaps in evidence.

The content of this podcast reflects the personal opinion of the author/s and is not necessarily the official position of the European Society of Cardiology.